Patient outcomes guidance in immunology

How to show value internally

Patient engagement and support solutions are becoming more widely used by pharmaceutical companies and other major health stakeholders in order to offer patients 360° support in their everyday lives and improve patient outcomes.
In this context it is critical to leverage data from patient solutions in order to evaluate their performance, encourage constant improvement and demonstrate their impact on patient health outcomes.
Our client, a global patient-centricity team in immunology from a top-15 pharmaceutical company, came to Observia to better understand how to help its affiliates consistently demonstrate the value of their patient services to each stakeholder.

Clear guidance highlighting main indicators & metrics

The guidance responded to two critical challenges: ensuring consistency across affiliates and offering managers a user-friendly methodology to ensure a facilitated collection of relevant patient outcomes data, while respecting associated legal requirements.
A co-construction initiative was led by the Observia team, who collaborated with the different departments (medical, marketing, market access, patient advocacy, regulatory, and legal) to understand the purpose of the guidance and how it could be used by local managers.

Based on their feedback, the client’s patients’ strategy and specific value proposition requirements (payers, patients & HCPs), Observia’s team built a user-friendly document incorporating our international expertise on these subjects.
Finally, a complete methodology, listing each patient outcomes indicator and measurement tool was developed. Once completed, the guidance was integrated into an e-learning tool for global distribution across countries.

 Get the detail of this methodology by downloading the full Success Story: